TheProfitWatch

SLRX - Salarius Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
4.1 0.41 (10.0%) --- 0.0 (0.0%) 0.01 (0.22%) 0.17 (4.15%) 0.46 (11.06%) -0.09 (-1.96%) -0.09 (-1.96%)

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.45
Diluted EPS:
-0.45
Basic P/E:
-10.0222
Diluted P/E:
-10.0222
RSI(14) 1m:
100.0
VWAP:
4.51
RVol:

Events

Period Kind Movement Occurred At

Related News